Author

Mayur M Patel

Associate Professor of Pharmaceutics, Institute of Pharmacy, Nirma University, Ahmedabad - Cited by 2,263 - Pharmaceutics - Novel Drug Delivery System - Colon Targeting

Biography

Dr. Mayur Patel, Associate Professor in Department of Pharmaceutics, has11 years of teaching experience. He has completed M.Pharm. and Ph. D. from Institute of Pharmacy, Nirma University. He has twenty one International and National Publications to his credit with total impact factor of more than 60, total citations more than 700 and ‘h’ index of 12. He has been invited to deliver lecture as a Resource Person at AICTE sponsored Two weeks Staff Development Programme. He is a life member of Professional bodies like APTI, IPA, IHPA, SOPI, ISTE and IPGA. He has authored books on “Practicals in Pharmaceutical Analysis.
Title
Cited by
Year
Threatening cancer with nanoparticle aided combination oncotherapy
S Rawal, MM PatelJournal of controlled release 301, 76-109, 2019201
142
2019
Cutting-edge technologies in colon-targeted drug delivery systems
MM PatelExpert opinion on drug delivery 8 (10), 1247-1258, 2011201
57
2011
Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis
NV Chokshi, HN Khatri, MM PatelDrug development and industrial pharmacy 44 (12), 1975-1989, 2018201
52
2018
Long-acting injectables: current perspectives and future promise
K Chaudhary, MM Patel, PJ MehtaCritical Reviews™ in Therapeutic Drug Carrier Systems 36 (2), 2019201
47
2019
Lipid nanoparticulate systems: Modern versatile drug carriers
SU Rawal, MM PatelLipid nanocarriers for drug targeting, 49-138, 2018201
45
2018
Getting into the colon: Approaches to target colorectal cancer
MM PatelExpert Opinion on Drug Delivery 11 (9), 1343-1350, 2014201
36
2014
Repurposing of sodium valproate in colon cancer associated with diabetes mellitus: Role of HDAC inhibition
MM Patel, BM PatelEuropean Journal of Pharmaceutical Sciences 121, 188-199, 2018201
30
2018
Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease
GK Sinhmar, NN Shah, NV Chokshi, HN Khatri, MM PatelDrug development and industrial pharmacy 44 (7), 1078-1089, 2018201
28
2018
Colon: a gateway for chronotherapeutic drug delivery systems
MM PatelExpert Opinion on Drug Delivery 12 (9), 1389-1395, 2015201
28
2015
Fabrication, optimization, and in vitro evaluation of docetaxel-loaded nanostructured lipid carriers for improved anticancer activity
P Mathur, S Sharma, S Rawal, B Patel, MM PatelJournal of liposome research 30 (2), 182-196, 2020202
27
2020
Formulation and development of di-dependent microparticulate system for colon-specific drug delivery
MM PatelDrug delivery and translational research 7, 312-324, 2017201
25
2017
Surface engineered lipid nanoparticle-mediated site-specific drug delivery system for the treatment of inflammatory bowel disease
GK Sinhmar, NN Shah, SU Rawal, NV Chokshi, HN Khatri, BM Patel, ...Artificial cells, nanomedicine, and biotechnology 46 (sup2), 565-578, 2018201
24
2018
Colon targeting: an emerging frontier for oral insulin delivery
MM PatelExpert Opinion on Drug Delivery 10 (6), 731-739, 2013201
21
2013
20
2019
Bio-nanocarriers for lung cancer management: Befriending the barriers
S Rawal, M PatelNano-Micro Letters 13 (1), 142, 2021202
18
2021
Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease
MM Patel, AF AminPharmaceutical development and technology 18 (2), 390-400, 2013201
17
2013
Oral delivery of anticancer agents using nanoparticulate drug delivery system
P Mathur, S Rawal, B Patel, MM PatelCurrent Drug Metabolism 20 (14), 1132-1140, 2019201
16
2019